Related references
Note: Only part of the references are listed.Proline-rich antimicrobial peptides show a long-lasting post-antibiotic effect on Enterobacteriaceae and Pseudomonas aeruginosa
Luzia Holfeld et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
C-terminal hydrazide modification changes the spinal antinociceptive profiles of endomorphins in mice
Chang-lin Wang et al.
PEPTIDES (2018)
Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo
Laszlo Otvos et al.
FRONTIERS IN CHEMISTRY (2018)
C-Terminal Modification and Multimerization Increase the Efficacy of a Proline-Rich Antimicrobial Peptide
Wenyi Li et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
The Effect of Selective D- or Nα-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20
Wenyi Li et al.
FRONTIERS IN CHEMISTRY (2017)
Correlating uptake and activity of proline-rich antimicrobial peptides in Escherichia coli
Luzia Holfeld et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2017)
Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model
Eszter Ostorhazi et al.
AMINO ACIDS (2017)
Colistin Reduces LPS-Triggered Inflammation in a Human Sepsis Model In Vivo: A Randomized Controlled Trial
P. Matzneller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
IMMUNOMODULATORY EFFECTS OF ANTI-MICROBIAL PEPTIDES
Laszlo Otvos
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2016)
Membrane interactions of proline-rich antimicrobial peptide, Chex1-Arg20, multimers
Wenyi Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Insect-derived short proline-rich and murine cathelicidin-related antimicrobial peptides act synergistically on Gram-negative bacteria in vitro
Daniel Knappe et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus
Mohamed F. Mohamed et al.
SCIENTIFIC REPORTS (2016)
C-Terminal Modifications Broaden Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20
Wenyi Li et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2015)
Short Proline-Rich Antimicrobial Peptides Inhibit Either the Bacterial 70S Ribosome or the Assembly of its Large 50S Subunit
Andor Krizsan et al.
CHEMBIOCHEM (2015)
Therapeutic utility of antibacterial peptides in wound healing
Laszlo Otvos et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis
Christian Bode et al.
JOURNAL OF ANTIBIOTICS (2015)
Insect-Derived Proline-Rich Antimicrobial Peptides Kill Bacteria by Inhibiting Bacterial Protein Translation at the 70S Ribosome
Andor Krizsan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
In Vitro and In Vivo Activities of Antimicrobial Peptides Developed Using an Amino Acid-Based Activity Prediction Method
Xiaozhe Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells
Ulrike Keitel et al.
INNATE IMMUNITY (2013)
Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureus
Eszter Ostorhazi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Michael Zahn et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Characterization of opioid activities of endomorphin analogs with C-terminal amide to hydrazide conversion
Chang-Lin Wang et al.
NEUROPEPTIDES (2013)
Antimicrobial Peptides: Multifunctional Drugs for Different Applications
Lars-Ove Brandenburg et al.
POLYMERS (2012)
Intramuscularly Administered Peptide A3-APO Is Effective Against Carbapenem-Resistant Acinetobacter baumannii in Mouse Models of Systemic Infections
Eszter Ostorhazi et al.
BIOPOLYMERS (2011)
Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved
Eszter Ostorhazi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models
Dora Szabo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections
Eszter Ostorhazi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use
Jacqueline M. Tarrant
TOXICOLOGICAL SCIENCES (2010)
Broad-spectrum antimicrobials and the treatment of serious bacterial infections: Getting it right up front
Marin H. Kollef
CLINICAL INFECTIOUS DISEASES (2008)
IL-10: The master regulator of immunity to infection
Kevin N. Couper et al.
JOURNAL OF IMMUNOLOGY (2008)
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics
Marco Cassone et al.
PEPTIDES (2008)
Cytokines, Inflammation, and Pain
Jun-Ming Zhang et al.
INTERNATIONAL ANESTHESIOLOGY CLINICS (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model
S. Ziegeler et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis
MD Howell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates
L Otvos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Taking inventory: antibacterial agents currently at or beyond Phase 1
K Bush et al.
CURRENT OPINION IN MICROBIOLOGY (2004)
In vitro and in vivo activity of an antibacterial peptide analog against uropathogens
M Cudic et al.
PEPTIDES (2003)
Development of novel antibacterial peptides that kill resistant isolates
M Cudic et al.
PEPTIDES (2002)
Antimicrobial peptides of multicellular organisms
M Zasloff
NATURE (2002)
The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding
G Kragol et al.
BIOCHEMISTRY (2001)
Susceptibility testing: accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values
RJW Lambert et al.
JOURNAL OF APPLIED MICROBIOLOGY (2000)
Share Paper
